Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
509
datasets available to search
ShareScore release 0.9.0
Dataset results
509 results for “Hepatitis C Virus”
A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT01070407. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patien
ClinicalTrials.gov study NCT00983060. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Biliverdin Reductase A in Chronic Hepatitis C Virus Infection
ClinicalTrials.gov study NCT01112033. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Opportunstic Hepatitis C Virus Treatment
ClinicalTrials.gov study NCT04220645. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection
ClinicalTrials.gov study NCT02723084. IPD Sharing: Not stated. Countries: 0. Publications: 3.
An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus in Participants Who Are Co-Infected With Human Immunodeficiency Virus:C-EDGE CO
ClinicalTrials.gov study NCT02105662. IPD Sharing: YES. Countries: 0. Publications: 4.
Hepatitis C Virus (HCV) Positive Kidney Grafts in HCV Negative Recipients
ClinicalTrials.gov study NCT04605679. IPD Sharing: NO. Countries: 1. Publications: 2.
Sofosbuvir/Ombitasvir/Paritaprevir/ Ritonavir and Ribavirin for Hepatitis C Virus Genotype 4 Patients
ClinicalTrials.gov study NCT04391985. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
ClinicalTrials.gov study NCT02642432. IPD Sharing: Not stated. Countries: 0. Publications: 6.
Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3)
ClinicalTrials.gov study NCT01121705. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis
ClinicalTrials.gov study NCT02219503. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT01995071. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Safety and Effectiveness of PRI-724 for Hepatitis C or B Virus Derived Liver Cirrhosis
ClinicalTrials.gov study NCT03620474. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Hepatitis C Virus and the Humoral Immune System
ClinicalTrials.gov study NCT00219999. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treatment of Recently Acquired Hepatitis C Virus Infection
ClinicalTrials.gov study NCT01336010. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Phase IV Trial of Paritaprevir/Ritonavir, Ombitasvir, Dasabuvir for Chronic Hepatitis C Genotype 1 Virus Infection
ClinicalTrials.gov study NCT02498015. IPD Sharing: NO. Countries: 1. Publications: 2.
Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection
ClinicalTrials.gov study NCT01587586. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study to Determine the Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Who Have Previously Failed Standard of Care
ClinicalTrials.gov study NCT01012895. IPD Sharing: Not stated. Countries: 3. Publications: 3.
Integrated Treatment of Hepatitis C Virus Infection
ClinicalTrials.gov study NCT03155906. IPD Sharing: NO. Countries: 1. Publications: 24.
Effects of HIV and Hepatitis C Virus on the Brain
ClinicalTrials.gov study NCT00494936. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.